174 related articles for article (PubMed ID: 22172290)
1. Delivery of salmon calcitonin using a microneedle patch.
Tas C; Mansoor S; Kalluri H; Zarnitsyn VG; Choi SO; Banga AK; Prausnitz MR
Int J Pharm; 2012 Feb; 423(2):257-63. PubMed ID: 22172290
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin-coated ZP-microneedle transdermal system: preclinical formulation, stability, and delivery.
Peters EE; Ameri M; Wang X; Maa YF; Daddona PE
Pharm Res; 2012 Jun; 29(6):1618-26. PubMed ID: 22258935
[TBL] [Abstract][Full Text] [Related]
3. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
du Plessis LH; Lubbe J; Strauss T; Kotzé AF
Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
[TBL] [Abstract][Full Text] [Related]
5. In vivo iontophoretic delivery of salmon calcitonin across microporated skin.
Vemulapalli V; Bai Y; Kalluri H; Herwadkar A; Kim H; Davis SP; Friden PM; Banga AK
J Pharm Sci; 2012 Aug; 101(8):2861-9. PubMed ID: 22644951
[TBL] [Abstract][Full Text] [Related]
6. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
[TBL] [Abstract][Full Text] [Related]
7. In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin.
Chaturvedula A; Joshi DP; Anderson C; Morris RL; Sembrowich WL; Banga AK
Int J Pharm; 2005 Jun; 297(1-2):190-6. PubMed ID: 15907605
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.
Baginski L; Gobbo OL; Tewes F; Salomon JJ; Healy AM; Bakowsky U; Ehrhardt C
Pharm Res; 2012 Jun; 29(6):1425-34. PubMed ID: 22322897
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of coated polymer microneedles for transdermal drug delivery.
Chen Y; Chen BZ; Wang QL; Jin X; Guo XD
J Control Release; 2017 Nov; 265():14-21. PubMed ID: 28344014
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
11. Dihydroergotamine mesylate-loaded dissolving microneedle patch made of polyvinylpyrrolidone for management of acute migraine therapy.
Tas C; Joyce JC; Nguyen HX; Eangoor P; Knaack JS; Banga AK; Prausnitz MR
J Control Release; 2017 Dec; 268():159-165. PubMed ID: 29051065
[TBL] [Abstract][Full Text] [Related]
12. Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug.
Ma Y; Gill HS
J Pharm Sci; 2014 Nov; 103(11):3621-3630. PubMed ID: 25213295
[TBL] [Abstract][Full Text] [Related]
13. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
[TBL] [Abstract][Full Text] [Related]
15. Formulation of hydrophobic peptides for skin delivery via coated microneedles.
Zhao X; Coulman SA; Hanna SJ; Wong FS; Dayan CM; Birchall JC
J Control Release; 2017 Nov; 265():2-13. PubMed ID: 28286315
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
[TBL] [Abstract][Full Text] [Related]
17. Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.
Youn YS; Kwon MJ; Na DH; Chae SY; Lee S; Lee KC
J Control Release; 2008 Jan; 125(1):68-75. PubMed ID: 18023905
[TBL] [Abstract][Full Text] [Related]
18. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
[TBL] [Abstract][Full Text] [Related]
20. Individually coated microneedles for co-delivery of multiple compounds with different properties.
Li S; Li W; Prausnitz M
Drug Deliv Transl Res; 2018 Oct; 8(5):1043-1052. PubMed ID: 29948917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
